This bill amends existing New Jersey law to allow health care providers to prescribe Schedule II controlled dangerous substances through telemedicine and telehealth without requiring an in-person examination or review of the patient. The new legal language specifies that an in-person examination is not necessary as long as the health care provider utilizes interactive, real-time, two-way audio and video technologies during the consultation. This change aims to enhance access to necessary medications while maintaining a standard of care.

Additionally, the bill includes provisions for prescribing stimulants classified as Schedule II controlled substances to minor patients under the age of 18 without an in-person examination, provided that written consent is obtained from a parent or guardian. The legislation emphasizes that health care providers must still adhere to the same standards of care as in-person settings and maintain comprehensive records of patient care. Overall, this bill seeks to modernize the approach to telemedicine in New Jersey, particularly concerning the prescription of controlled substances.

Statutes affected:
Introduced: 45:1-62